{
  "docId": "019dd923-5fed-74f2-a96f-1bdfa0f8925c",
  "docSlug": "bi-42cd9f0525110ab4",
  "documentTitle": "Here's dermatology startup Zerigo's Series B pitch deck",
  "authorId": "Pitchdecks",
  "authorName": "Zerigo Health",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "strategy_consulting",
  "sourceTypeLabel": "Strategy consulting",
  "presentationDate": null,
  "orientation": "landscape",
  "aspectRatio": 1.784,
  "pageNumber": 9,
  "pageCount": 17,
  "prevPage": 8,
  "nextPage": 10,
  "slideType": "appendix_data",
  "function": "analyze_data",
  "density": "overcrowded",
  "nDataPoints": 7,
  "notes": "Data covers Jan 2019 through June 2020.",
  "elementsJson": [
    "headline_text",
    "bullet_list",
    "donut_chart",
    "icon_grid",
    "footnote"
  ],
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019dd923-5fed-74f2-a96f-1bdfa0f8925c/9",
  "deckHref": "/decks/019dd923-5fed-74f2-a96f-1bdfa0f8925c",
  "deckJsonHref": "/decks/019dd923-5fed-74f2-a96f-1bdfa0f8925c.json",
  "deckAnchorHref": "/decks/019dd923-5fed-74f2-a96f-1bdfa0f8925c#slide-9",
  "components": [
    {
      "bbox": null,
      "kind": "callout",
      "text": "AI Biologic drugs accounted for 20% of all drug costs for members although only <1% use AI drugs.",
      "attrs": null,
      "subkind": null,
      "toolName": "Visual emphasis",
      "toolSlug": "visual-emphasis",
      "confidence": null,
      "componentId": "019dd952-b667-711e-a961-eb75b7b905e8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.1,
        "y": 0.48
      },
      "kind": "list",
      "text": "Only 1/158 patients requires an AI drug, but category spending increased 32% PMPM over 5 quarter period",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1ce6abc6-261a-4ff1-af1e-0f814cb21814",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.4,
        "x": 0.1,
        "y": 0.3
      },
      "kind": "list",
      "text": "AI Biologic drugs accounted for 20% of all drug costs for members although only <1% use AI drugs",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "26f1d00f-7be0-4a60-ae26-c27f394d1bf0",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.4,
        "x": 0.1,
        "y": 0.68
      },
      "kind": "list",
      "text": "Of the biggest 5 quarter PMPM increases for AI drugs, Psoriasis is #1 in PMPM costs and #1 in users per 100,000. Psoriasis alone represents 21.9% of the PMPM spend, up 28.9% over 5 qtr. to $6.93 PMPM",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7f54b3b5-d8ae-4df5-bc37-adaad3c66397",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.2,
        "w": 0.15,
        "x": 0.65,
        "y": 0.65
      },
      "kind": "metric",
      "text": "95%",
      "attrs": null,
      "subkind": "big-number",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3c58ed04-c2d6-4ec5-832f-91a8a54fca23",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": null,
      "kind": "metric",
      "text": "PMPM spend: 95%",
      "attrs": null,
      "subkind": "primary",
      "toolName": "Quantification",
      "toolSlug": "quantification",
      "confidence": null,
      "componentId": "019dd952-b667-711e-a961-ed236c65a9f7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.15,
        "x": 0.8,
        "y": 0.68
      },
      "kind": "paragraph",
      "text": "Seven total indications account for 95% of AI drug spend",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "49159983-8f2c-46fa-a690-e7e8ee61ed09",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.6,
        "x": 0.02,
        "y": 0.95
      },
      "kind": "source-note",
      "text": "1. Academy of Managed Care Pharmacy (AMCP) Annual Meeting, Prevalence and Cost of Autoimmune Specialty Drug Use by Indication in a Commercially Insured Population, April 13, 2021",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9a665b1c-fc28-468f-a918-92eda3460b4e",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.3,
        "x": 0.65,
        "y": 0.28
      },
      "kind": "table",
      "text": "RA, Psoriasis (PsO), Crohn's, PsO Arthritis, Ulcerative Colitis",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "2ad7fff8-1baa-4c4f-b541-cac0e1eedb24",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.3,
        "x": 0.65,
        "y": 0.18
      },
      "kind": "title",
      "text": "THE TOP 5 CLINICAL INDICATIONS ARE:",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0a3707f2-f6ee-49fb-ad66-71455569578c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.45,
        "x": 0.03,
        "y": 0.06
      },
      "kind": "title",
      "text": "NEW Prime Therapeutics Autoimmune (AI) Drug Data",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ba9eadb1-ddeb-403d-bcbe-6d156f06c23c",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "bd5481c4-c0a7-4d3a-bcfc-f7cb59ac56eb",
      "evidence": "table/data: RA, Psoriasis (PsO), Crohn's, PsO Arthritis, Ulcerative Colitis",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 10,
      "from": 7,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "065c9a5b-fd58-4fdf-b24c-97ee5669638d",
      "evidence": "Slides 7-10 discuss the cost of biologics and the need for alternative solutions",
      "position": 0,
      "objective": "Highlight the cost burden of biologics",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.8,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}